Back to Journal

SM Journal of Neurology and Neuroscience

Sural Nerve Schwannoma: A Case Report and Review of the Literature

[ ISSN : 2573-6728 ]

Abstract ABBREVIATION INTRODUCTION CASE PRESENTATION DISCUSSION CONCLUSION ACKNOWLEDGMENT REFERENCES
Details

Received: 22-Mar-2021

Accepted: 23-Apr-2021

Published: 30-Apr-2021

Ahmad Behzadpour¹*, Amanda Rivera¹, Jason Goodloe¹, Amatul Khan¹, Jaffer Shah², Hashim Talib Hashim³, Sherif Selim⁴, and Joseph Varney¹

¹American University of the Caribbean, School of Medicine, USA

²Drexel University College of Medicine, USA

³University of Baghdad, College of Medicine, USA

?George Washington University, USA

Corresponding Author:

Ahmad Behzadpour. 201-12510 Village Square Terrace, Rockville, MD. 20852. Tel: 321-5321098

Keywords

Schwannoma, Tumor, Peripheral Nerve, Benign

Abstract

Peripheral nerve sheet tumors (PNSTs) are exceedingly rare with the most tumors being benign. Schwannomas are one of the two types of PNSTs and have been classified as a slow-growing, benign neurogenic tumor composed of Schwann cells. Schwannomas have been shown to occur primarily in middle-aged patients with no gender prevalence. The variable clinical presentation of this tumor makes it a difficult diagnosis with symptoms being based on their location. Magnetic resonance imaging (MRI) is used to reveals the location, size, texture, and relationships with surrounding neuromuscular structures, with surgical excision being the primary treatment option with excellent outcomes. Our patient presented to the clinic due to left leg pain. MRI was utilized to diagnosis the tumor was a sural nerve tumor. The tumor was tan-pink in color and measured 6 cm in length and ranging from 0.4 cm to a central bulging aspect up to 2.5 cm for 3 cm with positive markers for S100. This case report explores patients’ clinical manifestations of a lower extremity schwannoma.

ABBREVIATION

Peripheral nerve sheet tumors (PNSTs), magnetic resonance imaging (MRI)

INTRODUCTION

Tumors of the peripheral nerve are rare, with the most common tumors being benign peripheral nerve sheet tumors (PNSTs) which include schwannomas and neurofibromas (1). Schwannomas have been classified as a slow-growing, benign neurogenic tumor composed of Schwann cells (2, 3). In the English literature, cases of focal schwannoma originating from the sural nerve are limited (4-6). Schwannomas have been shown to occur primarily in middle-aged patients (7) with no known gender-based risk factor for disease prevalence or severity (3).

Additionally, estimates of the prevalence of schwannomas in the lower extremity have been estimated to be less than 3%, highlighting the paucity of literature on this pathological finding (8). Schwannomas are benign, indeed encapsulated neoplasms that arise in peripheral nerve sheaths. Schwannomas have a variable clinical presentation based on their location.

These include incongruous nodules, dysphagia, dysarthria, compromised airway, and swelling (9). Tumors of large nerves typically present as eccentric masses that dislocate the nerve fibers (10), as clearly depicted in the schema reported in Rosai and Ackerman’s Surgical Pathology (11). As a result, they are generally easily resected with a minimal neural deficit by sparing most or all of the nerve bundles.

CASE PRESENTATION

An African American female, 61-years-old, presented to the clinic with chronic posterior and lateral left leg pain. The pain onset was said to be roughly three weeks, with the patient describing the pain as dull and achy. On a scale of 1-10, with 1 being practically no pain and 10 being the worst pain of one’s life, the patient reported a 5 out of 10 consistently throughout the day. The patient reports an 8 out of 10 when laid on or when standing for an extended period of time. Physical examination and further assessment with magnetic resonance imaging (MRI) disclosed a potential enfolded painful mass in the sural nerve. After surgical excision of the mass and pathology investigation, the diagnosis was confirmed to be a sural nerve schwannoma. The gross image of the schwannoma dissected out from the posterior compartment of our patient’s left leg is seen in Figure-1A. The tumor was tanpink in color and measured 6 cm in length and ranging from 0.4 cm to a central bulging aspect up to 2.5 cm for 3 cm. Pathologic microscopic examination showed classical histomorphologic features of schwannoma including proliferation of spindleshaped cells arranged in interlacing fascicles in mostly Antoni A areas, with scattered areas of edematous, hypocellular Antoni B areas. No significant atypia, abnormal mitosis or necrosis were detected. Features displayed in Figure-1B. Schwannoma cells were positive for S100 and negative for SMA, Desmin, and cD117, with appropriate controls. Sectioning of the well circumscribed bulging tumor revealed a tan glistening homogenous cut surface. The postoperative course was uneventful.

Figure 1: Gross and pathological examination of the excised mass. 1A: The excised schwannoma dissected from the left leg’s posterior compartment. The tumor was tan-pink, measuring 6 cm in length and ranging from 0.4 cm to a central bulging aspect up to 2.5 cm for 3 cm. 1B: The tumor shows classical histomorphologic features of schwannoma including proliferation of spindle-shaped cells arranged in interlacing fascicles in mostly Antoni A areas, with scattered areas of edematous, hypocellular Antoni B areas (H&E stain X40).

DISCUSSION

Schwannomas may originate from any peripheral nerve containing Schwann cells. However, schwannomas of the sural nerve are sporadic and exceedingly rare. The development of a schwannoma within the sural nerve is the primary focus of this case study. The function of the sural nerve is to supply sensory input to the lateral ankle and foot. It comprises two parts, the medial and lateral components from the tibial and common peroneal nerve, respectively. In locating the sural nerve, one could use the small saphenous vein for reference due to its proximity (12). Schwannoma of the foot and ankle can cause pain and swelling depending on their location. Many schwannomas consist of thickwalled vessels with changes in fibrinoid and hyaline adaptations (3). The position, scale, texture, and relationships surrounding neuromuscular structures are exposed using magnetic resonance imaging. Patients typically have a slow rising mass on the upper and lower extremities of the head, neck, and bending surfaces (3). The primary treatment choice is surgical excision, which has a high success rate (13).

Kim et al. reported a 30-year study out of Louisiana State University Health Sciences Center of 397 peripheral neural sheath tumors and found that roughly 91% of the tumors were benign. Of these benign peripheral neural sheath tumors, only one was found to be located on the sural nerve, which further stresses its rarity (5). Malignant peripheral nerve sheath tumors are a rare type of sarcoma found most often in deep soft tissues of the body. A unique case of malignant peripheral nerve sheath tumor associated with the sural nerve has also been reported. The tumor was removed surgically and sent to pathology for study. Despite multiple attempts to contact the patient, he refused further follow-up care and eventually refused to be seen at an oncologist (14).

been reported in the literature. A recent case report of pain in the lateral ankle in a 54-year-old female was found to be a sural nerve schwannoma. Surgical excision was completed in the diagnosis and treatment of the tumor (15). In a similar review, a solitary Schwannoma was reported in a 42-year-old male emerging from the sural nerve. On physical examination, a hard 3cm mobile and non-tender mass was noted. Magnetic resonance imaging showed an oval-shape subcutaneous mass with iso-signal intensity compared with normal skeletal muscle in T1- weighted sequences. In T2-weighted spectral presaturation, higher signal intensity was discovered peripherally, and less signal intensity was observed centrally representing a target sign. Contrastenhanced T1-weighted lines demonstrated a marked increase in the mass. The tumor was completely removed using an intracapsular biopsy technique. The histological examination determined that the patient had a schwannoma, with Antoni A tissue being a significant element. The patient has had no evidence of relapsing or residual symptoms, and they appear to be asymptomatic. Although rare, schwannoma should be considered when a well-defined, oval, subcutaneous mass in the lower leg is present (7).

Historically, the diagnostic imaging of choice is magnetic resonance imaging. Benign peripheral nerve tumors appear as well-defined masses inside the nerve, which are isointense to T1 image musculature and hyperintense to T2 image musculature (16, 17). As for the radiologic findings, sonography of ordinary schwannomas shows a well-defined hypo-echoic mass located along a nerve and eccentric to the nerve axis (18).

Although malignant tumors of the peripheral nerve sheath are not commonly seen, Rodriguez emphasized their diagnostic challenge and the importance of involving a multidisciplinary team of experienced pathologists to improve effective diagnosis and treatment (19). The surgical techniques and adjunctive therapies are presented, the tumors are classified with respect to type and prevalence at each neuroanatomical location, and the management of malignant PNSTs is reviewed. Surgical excision confirmed the diagnosis of a sural nerve schwannoma. Tumors were removed from 32 individuals (38 %). Of the ten nerve lesions, nine were found in the sciatic nerve and 1 in the tibial nerve. Eight of the ten sciatic nerve tumors were in the thigh region, and two were in the buttocks (5).

CONCLUSION

This case report explores patients’ clinical manifestations of a lower extremity schwannoma. Though rare, in patients with increasing lateral leg pain with a found tumor, a sural nerve tumor should be on the physician’s differential. Although they account for only a tiny proportion of the rare tumor group, they are still an important diagnosis that should be considered. Magnetic resonance imaging reveals the location, size, texture, and relationships with surrounding neuromuscular structures, with surgical excision being the primary treatment option with excellent outcomes (13).

ACKNOWLEDGMENT

We would like to thank doctors Mohamed Aziz and Navid Sadoughi for his outstanding mentorship and guidance.

REFERENCES

1. Phalen GS: Neurilemomas of the forearm and hand. Clin Orthop 114:219–222, 1976

2. Pundu A, Lehnert B. Schwannoma of the Sural Nerve: A Case Report. J Am Podiatr Med Assoc. 2020;110(3):Article_12. doi:10.7547/17-156.

3. Antonescu CR, Perry A and Woodruff JM: Schwannoma (including variants). In: World Health Organization Classification of Tumours of Soft Tissue and Bone. Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F (eds). 4th edition. IARC Press, Lyon, pp170-172, 2013.

4. Isobe K, Shimizu T, Akahane T, Kato H. Imaging of ancient schwannoma. American Journal of Roentgenology. 2004 Aug;183(2):331-6.

5. Kim DH, Murovic JA, Tiel RL, Moes G, Kline DG. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Centre. J Neurosurg 2005;102:246– 55.

6. Fellegara G, Bisceglia M. Intraneural schwannoma. International journal of surgical pathology. 2008 Jan;16(1):57-8.

7. Yamamoto K, Nishio J, Yano S, Naito M. Solitary schwannoma of the sural nerve: An unusual clinical presentation. Experimental and therapeutic medicine. 2014 Jan 1;7(1):90-2.

8. Odom RD, Overbeek TD, Murdoch DP, et al: Neurilemoma of the medial plantar nerve: a case report and literature review. J Foot Ankle Surg. 40: 105, 2001.

9. Sitenga, J., Aird, G., Nguyen, A., Vaudreuil, A., & Huerter, C. (2017). Clinical features and surgical treatment of SCHWANNOMA affecting the base of the Tongue: A systematic review. International Archives of Otorhinolaryngology, 21(04), 408-413. doi:

10.1055/s-0037-1598609 10.Scheithauer BW, Woodruff JM, Erlandson RA. Tumors of the Peripheral Nervous System. Atlas of Tumor Pathology. 3rd ed. Washington, DC: Armed Forces Institute of Pathology;1999:105-176.

11.Rosai J, ed. Rosai and Ackerman’s Surgical Pathology. Vol 2. 9th ed. St Louis, MO: Mosby; 2004.

12.Riedl O and Frey M: Anatomy of the sural nerve: cadaver study and literature review. Plast Reconstr Surg 131: 802-810, 2013.

13.Hao X, Levine D, Yim J, Qi C, Firestone L, Beiser I, Leone E, Woelffer K, Mirkin G. Schwannoma of foot and ankle: Seven case reports and literature review. Anticancer research. 2019 Sep 1;39(9):5185-94.

14.Nicklas BJ, Smith AD, Wolff RD, Johnson FA. Malignant peripheral nerve sheath tumor arising in association with the sural nerve. The Journal of foot and ankle surgery. 2006 Jan 1;45(1):38-41.

15.Bilenki JM, Platt S. Sural nerve schwannoma: A case report. The Foot. 2020 Dec 1;45:101746.

16.Thawait SK, Chaudhry V, Thawait GK, Wang KC, Belzberg A, Carrino JA, et al. High-resolution MR neurography of diffuse peripheral nerve lesions. Am J Neuroradiol. 2011;32(8):1365–72.

17.Villanova JC, Woertler K, Narvaez JA, Barcelo J, Martinez SJ, Villalon M, et al. Soft-tissue tumors update: MR imaging features according to the WHO classification. Eur Radiol 2007;17(1):125–38.

18.Fornage BD. Peripheral nerves of the extremities: imaging with US. Radiology 1988;167:179–182

19.Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol 2012;123(3):295–319.

Citation

Behzadpour A, Rivera A, Goodloe J, Khan A, Shah J, et al. (2021) Sural Nerve Schwannoma: A Case Report and Review of the Literature. SM J Neurol Neurosci 7: 3.

Other Articles

Article Image 1

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and Obsessive Compulsive Disorder Risk

Brain-Derived Neurotrophic Factor (BDNF) is required for neuron growth and maintenance. Single nucleotide polymorphisms (SNP) are reported in BDNF gene, which reduces proteins activity, Val66Met polymorphism is very well studied and reported as a risk factor for psychiatric diseases. Numerous case-control studies have evaluated the role BDNF Val 66Met (dbSNP: rs6265;196G>A) polymorphism in OCD susceptibility and provided ambiguous findings, hence present meta-analysis was designed to get an exact association between BDNF Val66Met polymorphism and OCD risk. A total of 14 case - control articles were identified through PubMed, Google Scholar, Science Direct and Springer link databases search, up to July 11, 2024. Odds ratios (ORs) with 95% con¬fidence intervals (CIs) were used as association measure. All statistical analyses were done by MetaDiSc (version 1.4).

Fourteen case-control studies involving 2,765 OCD cases and 5,585 controls were included in present meta-analysis. The results showed that the BDNF Val66Met polymorphism was not associated with OCD risk (allele contrast odds ratio ORAvsG = 0.96, 95% CI= 0.82-1.12, p= 0.000; homozygote ORAAvsGG = = 0.79, 95%CI= 0.59-1.06, p= 0.0058; dominant model ORAA+GAvsGG = 0.96, 95%CI= 0.86-1. 06, p= 0.17). In conclusion, the BDNF Val66Met polymorphism was not related to increased OCD susceptibility.

Vandana Rai, Pradeep Kumar, and Abhishek Kannojiya*


Article Image 1

The F-Wave and H-Reflex Patterns with Increased Stimulus Intensity in Patients with Cerebrovascular Disease for the Neurological Evaluation of Affected Arm or Leg

The F-wave is a result of α-motor neurons backfiring following an antidromic invasion of propagated impulses across the axon hillock.

Suzuki T*


Article Image 1

A Typical Anatomy of the Hand Representation in Adults who Stutter

Atypical hand preference may be more common in Adults Who Stutter (AWS). One implication is that stuttering may be a manifestation of a more general dysfunction in motor organization and planning. This study was designed to determine whether AWS have atypical motor cortical anatomy compared to controls, and whether there are group differences in handedness that correlate with anatomical measures. Volumetric MRI was used to measure the anterior bank of the Central Sulcus (CS) and Motor Knob (MK), a structure that corresponds precisely to the motor hand representation, in Adults Who Stutter (AWS) and fluent, matched controls divided into three groups (right-handed and left-handed men, right-handed women). There was an interaction between fluency group and handedness-sex group (p=0.024) with reduced CS volume in right-handed men who stutter (p=0.001). For MK volume there was an interaction with the right MK larger in the left-handed male controls, and the left MK larger in the left-handed AWS (p=0.024). AWS and controls did not differ in hand preference score or finger tapping rate. There was a relationship between CS asymmetry and finger-tapping laterality (p=0.042) with a faster right-hand tapping speed associated with a larger left CS and vice-versa. When controls were examined independently, there were no correlations between finger-tapping laterality and anatomical asymmetry; there was a correlation in the AWS (r= 0.642; p= 0.007). Left hander AWS tapped faster with the right hand and had a larger left CS (atypical). One subgroup of right handed AWS (atypical) tapped faster with the left hand and had a larger right CS. Another subgroup of right handed AWS (typical) tapped faster with the right hand and had a larger left CS. These results show that handedness may systematically influence cortical motor representations in AWS. Further study is warranted in a larger sample of adults and in children who stutter.

Foundas LA¹*, Baucom CC², Knaus TA³, and Corey DM⁴


Article Image 1

Ischemic Stroke at Jordan University Hospital: A One-Year Hospital-Based Study of Subtypes and Risk Factors

Objective: To study the ischemic stroke subtypes and risk factors in 100 patients observed at Jordan University Hospital (JUH) over a one-year-period, and to compare the results with another 100 age-and –sex matched controls as well as with studies from other Arab countries.

Methods: One hundred patients with first-ever ischemic stroke admitted to JUH over a one-year period (between January 2013 to January 2014) were studied.

Results: There were 62 males and 38 females (M/F ratio=1. 6), with a mean age of 66 years (range 22-90 years), the majority (80/100) between the age 51-80 years. The most common stroke subtype was lacunar infarcts (36 patients). Fourty-two out of 51 patients had intracranial atherosclerosis. The most common risk factor was hypertension (85%) followed by hyperlipidemia (71%) and diabetes mellitus (65%).

Conclusion: In accordance with other Arab studies and controls, hypertension was the predominant risk factor but lacunar infarcts were more common than in most reports from other Arab countries . This shows the importance of appropriate management of hypertension to reduce the incidence of stroke in Jordan.

Bahou Y*, Ajour M, and Jaber M


Article Image 1

Longitudinal Language Changes Associated with MRI Anatomy in Children with Autism Spectrum Disorder

Background: Language ability is one of the strongest predictors of prognosis and developmental course in Autism Spectrum Disorder (ASD). A range of language abilities occur in ASD and although many have delays in language it remains unclear why some children’s language continues to lag, while others do not. Abnormal anatomy and function of language-related regions has been found in ASD, however, how these differences relate to language development over time is undetermined.

Methods: This study examined longitudinal changes in language functions in children with ASD and investigated whether cortical language region anatomy was related to these changes in language. Eighteen boys with ASD, 2-8 years old were evaluated (Time 1) and re-examined about 3.5 years later (Time 2) at ages 7-10. MRIs were collected at Time 2 to evaluate gray matter volume of anterior (Pars Triangularis, PTR; pars opercularis, POP) and posterior (Planum Temporale, PT; Posterior Superior Temporal Gyrus, pSTG) language regions and the microstructure of the arcuate fasciculus.

Results: Eleven boys had relative decline in language functions (decline group) and 7 boys had no relative change in language (no change group). The no change group had larger PT and right PTR volume relative to the decline group. In addition, the right PTR was correlated with the language change score, with larger right PTR associated with less language decline. There was a trend for non-right-handers to have more language decline than right-handers.

Conclusions: Results suggest differences in cortical language anatomy may play a role in language development, with further studies warranted.

Tracey A Knaus¹˒²*, Jodi Kamps³˒⁴, and Anne L Foundas⁵


Article Image 1

A New Analysis Method of F-Waves to Obtain

From the observation of different F-wave waveforms, we introduce a new method of differentiating these waveforms, by assigning each with an “F-wave waveform value”, which can be used in the clinic to evaluate the effects of rehabilitation. F-wave waveform values were determined by creating a window from minimum onset latency to maximum onset latency in measurable waveforms. We then calculated the correlation coefficient of each waveform, using Microsoft Excel, and identified F-waves as those with a correlation coefficient of greater than 0.9 or equal to 1.0. The number of different F-wave waveforms types was determined from the number of identified waveforms. We applied F-wave waveform values to evaluate neurophysiological change and the effects of rehabilitation following hemiplegia. In the future, F-wave waveform values should be considered as an important tool when assessing the effects of rehabilitation on impaired neurological responses.

Toshiaki Suzuki¹˒²*, Yoshibumi Bunno¹˒², Makiko Tani¹˒², Chieko Onigata², Yuuki Fukumoto¹, Marina Todo², Hirofumi Watanabe³, Toshihiro Ohnuma¹˒²˒³, and Naoko Komatsu³


Article Image 1

Neuroprotective Effect of Organic and Conventional White Grape Juice against Carbon Tetrachloride Damage in Different Brain Areas of Rats

The consumption of nutrients containing phenolic compounds has been reported due to the benefits they produce on human health. Therefore, the objective of this study was to investigate the antioxidant and neuroprotective effect of the administration of organic (OGJ) and conventional (CGJ) white grape juices from Niagara variety on the oxidative stress in cerebral cortex, hippocampus and cerebellum after the treatment with carbon tetrachloride (CCl4 ) as well as on some biochemical parameters in serum of rats. Adult male rats (~300g; n=6-8/group) were orally treated (gavage) with 7μL/g of OGJ, CGJ or water, for a period of 14 days. On the 15th day it was administered CCl4 (3.0mL/kg). After 4h the animals were euthanized and the cerebral cortex, hippocampus and cerebellum were dissected and used for the analysis of oxidative stress parameters. We observed that CCl4 enhanced lipid peroxidation (TBARS) and protein damage (carbonyl), reduced the nonenzymatic antioxidants defenses (sulfhydryl), and changed the activity of the enzymatic antioxidants defenses catalase (CAT), Superoxide Dismutase (SOD) in the brain of rats. CCl4 also enhanced glucose, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST) and Gamma-Glutamyl (GGT) and decreased total cholesterol and High-Density Lipoprotein (HDL) in serum of rats. CGJ and OGJ were able to prevent or ameliorate most of these alterations. Consequently, regular intake of white grape juice could be considered as an adjuvant in the therapy of oxidative damages, revealing a possible antioxidant and neuroprotective agent.

Clarice M. Peripolli, Tatiane Gabardo, Fernanda de Souza Machado, Mariane Wohlenberg, Juliana D.O. Lima, Alice S. Oliveira, Marina Rocha Frusciante, Niara da Silva Medeiros, Sheila Pereira Feijó, Filipe V.V. Nascimento, Caroline Dani, and Cláudia Funchal


Article Image 1

Global Evidence for the Key Role of the Dopamine D2 Receptor Gene (DRD2) and DRD2 Receptors in Alcoholism

It has been over 27 years since Blum & Noble discovered the first association of the DRD2 A1 allele in severe alcoholism, suggesting reward as the real phenotype, not alcoholism. This has been acknowledged by an explosion of research in the arena of Psychiatric Genetics. To date, a PubMed search listed 6,839 studies (5-15- 17). The A1 allele has been associated with substance use disorders other than alcoholism, including cocaine, nicotine dependence, polysubstance abuse and many Reward Deficiency Syndrome (RDS) behaviors substance and non-substance related. Certainly following extensive controversy, the emerging evidence suggests that the DRD2 is a reinforcement or reward gene. In fact, it could represent one of the most prominent single-gene determinants of susceptibility to severe substance abuse/reward deficiency. While, however, the environment through epigenetic impact and other genes, when combined, still play the larger role, targeting the DRD2 gene through the novel genetic rewriting of the DNA code at the mRNA level may hold the greatest promise to date for potentially “curing” the RDS phenotype.

Kenneth Blum¹⁻⁹˒¹²*, Mark S Gold²˒¹⁵, Lloyd G Mitchell¹⁰˒¹¹, Kareem W Washington¹⁰, David Baron², Panayotis K Thanos¹³, Bruce Steinberg¹⁴, Edward J Modestino¹⁴, Lyle Fried⁷, and Rajendra D Badgaiyan¹²


Article Image 1

Depression in Alzheimer

Background: Pharmacological treatment for AD and depression are unfortunately few and of limited efficacy to cure the disease.

Objectives: To assess the combined effects of rivastigmine and citalopram on Alzheimer’s Disease.

Methods: Longitudinal clinical prospective study with 1278 AD patients on rivastigmine 9,5mg/patch and citalopram 20-40 mg/day over 48 months was assessed on the basis of NINCDS-ADRDA, MMSE, DSM-IV, FRSSD, GDS, HRS-D and follow up of the patients.

Results: Four years after the baseline assessment, there were no significant differences in MMSE, Geriatric depression scale and Hamilton rating scale for depression between patients treated with rivastigmine alone or combined rivastigmine with citalopram with or without depression (p>0.05). Functional Rating Scale for symptoms of dementia, Activities of Daily Living of patients with AD and depression treated with rivastigmine was significantly worse than patients treated with rivastigmine and no depression (p=0.027).

Conclusions: The combination of rivastigmine and citalopram had no better results than rivastigmine alone in patients with AD.

Magda Tsolaki*, Krishna Prasad Pathak, Eleni Verikouki, Chaido Zchou Messini, Tara Gaire, and Paschalis Devranis


Article Image 1

Anxiety and Its Features in Parkinson

Anxiety is one of the most clinically significant psychiatric syndromes in Parkinson’s Disease (PD). It is estimated to affect up to 50% of individuals with PD and is associated with higher levels of dependency and poorer quality of life. Although it is common, it remains widely under recognised by patients, carers and clinicians, and has not been extensively studied [1]. Therefore, in spite of its significant impact, the symptomatology, chronology, and neurobiology of anxiety in PD are not well understood.

Recently, anxiety in PD has been associated with increases in motor fluctuations and gait disturbances including freezing. Freezing of gait (FOG) is the temporary inability to walk and is one of the most debilitating symptoms of PD. It is associated with an increase in falls, injuries and dependency. The associations with motor symptoms have significant consequences for the quality of life of people living with PD. This review summarizes the most recent data on the epidemiology, associated features and possible mechanisms underlying anxiety in PD.

Perri Carlson-Hawke¹˒²*, Belinda Brown², and Simon Hammond¹